Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
December 13 2024 - 7:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission file number: 001-13738
_______________________________
PSYCHEMEDICS CORPORATION
The Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange
where security is listed and/or registered)
_______________________________
5220 Spring Valley Road, Suite 230
Dallas, Texas
(800) 527-7424
(Address, including zip code, and telephone number, including area code,
of Issuer’s principal executive offices)
_______________________________
Common Stock, par value $0.005 per share
(Description of class of securities)
_______________________________
Please place an X in the box to designate the rule provision relied upon to strike the class
of securities from listing and registration:
| ☐ |
17 CFR 240.12d2-2(a)(1) |
| ☐ |
17 CFR 240.12d2-2(a)(2) |
| ☐ |
17 CFR 240.12d2-2(a)(3) |
| ☐ |
17 CFR 240.12d2-2(a)(4) |
| ☐ |
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1 |
| ☒ |
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange. |
1 Form 25 and attached Notice will be considered
compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions
Pursuant to the requirements of the Securities Exchange Act of 1934, Psychemedics Corporation certifies
that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification
to be signed on its behalf by the undersigned duly authorized person.
| December 13, 2024 |
|
By: |
Brian Hullinger |
|
President and Chief Executive Officer |
| Date |
|
|
Name |
|
Title |
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
From Nov 2024 to Dec 2024
Psychemedics (NASDAQ:PMD)
Historical Stock Chart
From Dec 2023 to Dec 2024
